Abstract
The main objectives of this study were to assess the use of irinotecan, 5-fluorouracil (5-FU), and leucovorin (FA) as neoadjuvant chemotherapy for patients with unresectable colorectal liver metastases and to determine the response rate and proportion of patients that could be downstaged to resectable tumors. Forty patients were treated with irinotecan (180 mg/m2 over 30 min) on d 1, FA (200 mg/m2 over 30 min) followed by 5-FU (400 mg/m2 bolus and continuous infusion of 600 mg/m2 over 22 h) on d 1 and 2 every 2 wk. The overall response rate was 55% (95% CI: 39.5–70.4%). The progression-free survival was 12.1 mo (95% CI: 11.4–14.8 mo). The median overall survival was 20 mo (95% CI: 17.7–26.6 mo). Four patients (10%) have undergone liver resection after a median of eight cycles. Those patients remained alive with a median follow up period of 33 mo. The principal grade 3–4 toxicity was neutropenia in 20 patients (50%). We conclude that the regimen of irinotecan/5-FU/FA was highly active in patients with colorectal cancer and liver metastases with limited toxicity. In a subgroup of patients with initial inoperable liver metastases, this regimen was able to downstage the disease to an operable stage.
Similar content being viewed by others
References
Jemal A, et al. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23–47.
Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023–1033.
Wilertt CG, et al. Failure patterns following curative resection of colonic carcinoma. Ann Surg 1984;200:685–690.
Stangl R, et al. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405–1410.
Scheele J, et al. Resection of colorectal liver metastases. World J Surg 1995;19:59–71.
Zadavski KE, et al. Liver metastases from colorectal carcinoma: incidence, resectability and survival results. Ann Surg 1994;60:929–932.
Bismuth H, et al. Resection of non resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surgery 1996;224:509–522.
Giacchetti S, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first line treatment of metastatic colorectal cancer. J Clin Oncol 2000;18:136–147.
Giacchetti S, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663–669.
Fowler WC, Eisenberg BL, Hoffman JP. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol 1992;51:122–125.
Alberts SR, et al. Oxaliplatin, 5-flurouracil, and leucovorin for patients with liver only metastases from colorectal cancer: a North Central Cancer Treatment Group Phase II study. Proc Am Soc Clin Oncol 2001;19:511.
Douillard JY, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 2000;355:1041–1047.
Saltz LB, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Eng J Med 2000;343:905–914.
WHO. Handbook for reporting results of cancer treatment. WHO: Geneva, 1979.
Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10:1–10.
De Gramont A, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938–2947.
Rivoire M, et al. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma. Cancer 2002;95:2283–2292.
Hurwitz H, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–2342.
Cunningham D, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337–345.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ho, W.M., Ma, B., Mok, T. et al. Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases. Med Oncol 22, 303–312 (2005). https://doi.org/10.1385/MO:22:3:303
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/MO:22:3:303